Literature DB >> 23717975

[Study on in situ intestinal absorption of baicalin contained in Tiangou Jiangya capsules].

Ling-Jun Li1, Ji Li, Hua-Wei Lou.   

Abstract

OBJECTIVE: To study in situ intestinal absorption kinetics of baicalin contained in Tiangou Jiangya capsules, and the effect of different intestinal segments, pH value, drug concentration and P-gp inhibitor on the absorption.
METHOD: The in situ intestinal perfusion test was adopted, and HPLC method was used to determine the content of baicalin in samples at different time points. Ultra-violet (UV) spectrophotometry was used to determine the content of phenol red in samples at different time points. RESULT: When pH value was at 5. 0, 6. 5, 7. 4, the absorption of baicalin was not impacted. P-gp inhibitor verapamil could enhance the absorption of baicalin. When the quality concentration of the test solution ranged between 5-20 g L -1 , the linearity of the absorption amount of baicalin increased. The absorption kinetic equation of baicalin was Y = -0. 073 7X +0. 118 7 (r = 0. 994 8) , K. 0. 073 7 h -1 , t1/2 9. 40 h.
CONCLUSION: Baicalin is mainly absorbed in colon. The absorption of baicalin shows the first-order kinetics process, with the absorption mechanism of passive diffusion. Baicalin is a substrate for P-gp.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23717975

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  The pharmacokinetics of Tiangou antihypertensive capsule in rat in vivo.

Authors:  Ji-Zheng Song; Ling-Jun Li; Li Ji; Li Shun; Yan Rui
Journal:  Biomed Rep       Date:  2016-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.